Traders sold shares of Express Scripts Holding Co (NASDAQ:ESRX) on strength during trading hours on Wednesday. $147.42 million flowed into the stock on the tick-up and $210.33 million flowed out of the stock on the tick-down, for a money net flow of $62.91 million out of the stock. Of all companies tracked, Express Scripts had the 0th highest net out-flow for the day. Express Scripts traded up $2.88 for the day and closed at $89.83
Several research analysts have weighed in on the company. Royal Bank of Canada upped their price target on Express Scripts to $94.00 and gave the stock an “outperform” rating in a research note on Monday, August 27th. William Blair upgraded Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. BidaskClub upgraded Express Scripts from a “sell” rating to a “hold” rating in a research note on Tuesday, July 31st. Zacks Investment Research downgraded Express Scripts from a “hold” rating to a “sell” rating in a research note on Monday, July 23rd. Finally, Robert W. Baird downgraded Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price target for the company. in a research note on Friday, July 20th. Three investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $85.58.
The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69. The stock has a market cap of $50.50 billion, a P/E ratio of 12.71, a P/E/G ratio of 1.13 and a beta of 1.00.
Express Scripts (NASDAQ:ESRX) last posted its earnings results on Wednesday, August 1st. The company reported $2.22 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $0.02. The firm had revenue of $25.64 billion during the quarter, compared to the consensus estimate of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The company’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.73 EPS. equities analysts expect that Express Scripts Holding Co will post 9.07 EPS for the current year.
In other news, insider Christine Houston sold 12,898 shares of the stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the completion of the transaction, the insider now directly owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.79% of the stock is currently owned by corporate insiders.
Large investors have recently added to or reduced their stakes in the stock. Hendershot Investments Inc. raised its holdings in shares of Express Scripts by 2.7% in the 2nd quarter. Hendershot Investments Inc. now owns 89,125 shares of the company’s stock valued at $6,881,000 after buying an additional 2,380 shares during the period. Stock Yards Bank & Trust Co. purchased a new position in shares of Express Scripts in the second quarter worth $1,084,000. Reinhart Partners Inc. purchased a new position in shares of Express Scripts in the second quarter worth $20,509,000. Systematic Financial Management LP purchased a new position in shares of Express Scripts in the first quarter worth $1,129,000. Finally, Commonwealth Bank of Australia increased its stake in shares of Express Scripts by 15.6% in the second quarter. Commonwealth Bank of Australia now owns 296,858 shares of the company’s stock worth $22,915,000 after buying an additional 39,983 shares during the period. Institutional investors own 84.71% of the company’s stock.
Express Scripts Company Profile (NASDAQ:ESRX)
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Article: What Factors Can Affect Return on Equity?
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.